De Benedetti, F., Ruperto, N., Brunner, H., Grom, A., Wulffraat, N., Henrickson, M., . . . Lovell, D. (2013). PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study. BioMed Central.
Citación estilo ChicagoDe Benedetti, F., et al. PReS-FINAL-2139: Tapering and Withdrawal of Tocilizumab in Patients With Systemic JIA in Inactive Disease: Results From an Alternative Dosing Regimen in the Tender Study. BioMed Central, 2013.
Cita MLADe Benedetti, F., et al. PReS-FINAL-2139: Tapering and Withdrawal of Tocilizumab in Patients With Systemic JIA in Inactive Disease: Results From an Alternative Dosing Regimen in the Tender Study. BioMed Central, 2013.